Tissue renin-angiotensin system: A site of drug action?

Annual Review of Pharmacology and Toxicology

Volumn 37, Issue , 1997, Pages 53-69

  Zimmerman, Ben G ^a   Dunham, Earl W ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

ACE inhibitors; AT1 angiotensin antagonists; blood pressure; kidney; renal blood flow

Indexed keywords

ANGIOTENSIN ANTAGONIST; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LISINOPRIL; LOSARTAN; PERINDOPRIL; RAMIPRIL; REMIKIREN; RENIN INHIBITOR; RENTIAPRIL; SARALASIN; TEPROTIDE;

ANIMAL EXPERIMENT; BLOOD PRESSURE; KIDNEY BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; KIDNEY; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; RENIN; RENIN-ANGIOTENSIN SYSTEM;

ANIMALIA;

EID: 0030995877     PISSN: 00664251     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (88)

1. Dzau VJ, Ellison KE, Brody T, Ingelfinger J, Pratt RE. 1987. A comparative study of the distribution of renin and angiotensin messenger ribonucleic acids in rat and mouse tissues. Endocrinology 120:2334-38
2. Dzau VJ, Burt DW, Pratt RE. 1988. Molecular biology of the renin-angiotensin system. Am. J. Physiol. 255:F563-73
3. Dzau VJ. 1984. Vascular renin-angiotensin: a possible autocrine or paracrine system in control of vascular function. J. Cardiovasc. Pharmacol. 6:S377-82
4. Kato H, Iwai N, Inui H, Kimoto K, Uchiyama Y, Inagami T. 1993. Regulation of vascular angiotensin release. Hypertension 21:446-54
5. Campbell DJ, Kladis A, Duncan A-M. 1993. Nephrectomy, converting enzyme inhibition, and angiotensin peptides. Hypertension 22:513-22
6. Li T, Zimmerman BG. 1991. β-adrenergic-induced local angiotensin generation in the rabbit hind limb is dependent on the kidney. Hypertension 17:1010-17
7. Danser AH, van Kats JP, Admiraal PJ, Derkx FH, Lamers JM, Verdouw PD, et al. 1994. Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis. Hypertension 24:37-48
8. Schmidt HE. 1962. Renin, a physiological regulator of renal hemodynamics. Circ. Res. 11:185-93
9. Thurau K. 1964. Renal hemodynamics. Am. J. Med. 36:698-719
10. Krahe P, Hofbauer KG, Gross F. 1970. Effects of endogenous renin on the function of the isolated kidney. Life Sci. 9:1317-20
11. Franklin WG, Peach MJ, Gilmore JP. 1970. Evidence for the renal conversion of angiotensin I in the dog. Circ. Res. 27:321-24
12. DiSalvo J, Peterson A, Montefusco C, Menta M. 1971. Intrarenal conversion of angiotensin I to angiotensin II in the dog. Circ. Res. 29:398-406
13. Hofbauer KG, Zschiedrich H, Rauh W, Gross F. 1973. Conversion of angiotensin I into angiotensin II in the isolated perfused rat kidney. Clin. Sci. 44:447-56
14. Levens NR, Peach MJ, Carey RM. 1981. Role of the intrarenal renin-angiotensin system in the control of renal function. Circ. Res. 48:157-67
15. Mimran A, Guiod L, Hollenberg NK. 1974. The role of angiotensin in the cardiovascular and renal response to salt restriction. Kidney Int. 5:348-55
16. Kimbrough HM, Vaughan ED Jr, Carey RM, Ayers CR. 1977. Effect of intrarenal angiotensin II blockade on renal function in conscious dogs. Circ. Res. 40:174-78
17. Lohmeier TW, Cowley AW Jr, Trippodo NC, Hall JE, Guyton AC. 1977. Effects of endogenous angiotensin II on renal sodium excretion and renal hemodynamics. Am. J. Physiol. 233:F388-95
18. Wong PC, Zimmerman BG. 1980. Role of extrarenal and intrarenal converting enzyme inhibition in renal vasodilator response to intravenous captopril. Life Sci. 27:1291-97
19. Wong PC, Zimmerman BG. 1981. Comparison of intrarenal and extrarenal converting-enzyme inhibition by SQ 20881 on canine renal blood flow. Clin. Sci. 61:553-57
20. Zimmerman BG, Wong PC, Kounenis GK, Kraft EJ. 1982. No effect of intrarenal converting enzyme inhibition on canine renal blood flow. Am. J. Physiol. 243:H277-83
21. Siragy HM, Howell NL, Peach MJ, Carey RM. 1990. Combined intrarenal blockade of the renin-angiotensin system in the conscious dog. Am. J. Physiol. 258:F522-29
22. Hall JE, Coleman TG, Guyton AC, Kastner PR, Granger JP. 1981. Control of glomerular filtration rate by circulating angiotensin II. Am. J. Physiol. 241:R190-97
23. Kastner PR, Hall JE, Guyton AC. 1984. Control of glomerular filtration rate: role of intrarenally formed angiotensin II. Am. J. Physiol. 246:F897-906
24. Wong PC, Zimmerman BG, Friedman P. 1981. Release of PGE and PGI2 in the pump-perfused dog kidney and associated hypotension. Am. J. Physiol. 240:F545-50
25. Cohen ML, Kurz KD. 1982. Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421. J. Pharmacol. Exp. Ther. 220:63-69
26. Unger T, Ganten D, Lang RE, Scholkens BA. 1984. Is tissue converting enzyme inhibition a determinant of the antihypertensive efficacy of converting enzyme inhibitors? Studies with the two different compounds, Hoe498 and MK421, in spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 6:872-80
27. Unger T, Ganten D, Lang RE, Scholkens BA. 1985. Persistent tissue converting enzyme inhibition following chronic treatment with Hoe498 and MK421 in spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 7:36-41
28. Wood JM, Schnell CR, Levens NR. 1993. Kidney is an important target for the antihypertensive action of an angiotensin II receptor antagonist in spontaneously hypertensive rats. Hypertension 21:1056-61
29. Muirhead EE. 1993. Renal vasodepressor mechanisms: the medullipin system. J. Hypertension 11(Suppl. 5):S53-58
30. Gardiner SM, March JE, Kemp PA, Mullins JJ, Bennett T. 1995. Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats. Br. J. Pharmacol. 116:2237-44
31. Lu S, Mattson DL, Cowley AW Jr. 1994. Renal medullary captopril delivery lowers blood pressure in spontaneously hypertensive rats. Hypertension 23:337-45
32. Bailie MD, Rector FC Jr, Seldin DW. 1971. Angiotensin II in arterial and renal venous plasma and renal lymph in the dog. J. Clin. Invest. 50:119-26
33. Oparil S, Sanders CA, Haber E. 1970. In-vivo and in-vitro conversion of angiotensin I to angiotensin II in dog blood. Circ. Res. 26:591-99
34. Oparil S, Bailie MD. 1973. Mechanism of renal handling of angiotensin II in the dog. Circ. Res. 33:500-7
35. Rosivall L, Narkates AJ, Oparil S, Navar LG. 1987. De novo intrarenal formation of angiotensin II during control and enhanced renin secretion. Am. J. Physiol. 252:F1118-23
36. Nussberger J, Brunner DB, Waeber B, Brunner HR. 1986. Specific measurement of angiotensin metabolites and in vitro generated angiotensin II in plasma. Hypertension 8:476-82
37. Nakamaru M, Jackson EK, Inagami T. 1986. Beta-adrenoceptor-mediated release of angiotensin II from mesenteric arteries. Am. J. Physiol. 250:H144-48
38. Mizuno K, Higashimori K, Imada T, Inagami T. 1987. Direct release of angiotensins I and II from isolated rat kidney perfused with angiotensinogen-free medium. Biochem. Biophys. Res. Commun. 149:475-81
39. Mizuno K, Higashimori K, Inagami T. 1988. Direct evidence for the local generation of vascular angiotensin II and its prostaglandin-mediated release from isolated hind legs in the rat. J. Hypertension 6(Suppl. 4):S435-37
40. Hilgers KF, Kuczera M, Wilhelm MJ, Wiecek LA, Ritz E, Ganten D. 1989. Angiotensin formation in the isolated rat hindlimb. J. Hypertension 7:789-98
41. Misumi J, Gardes J, Gonzalez M-F, Corvol P, Menard J. 1989. Angiotensinogen's role in ANG formation, renin release, and renal hemodynamics in isolated perfused kidney. Am. J. Physiol. 256:F719-27
42. McElroy ND, Zimmerman BG. 1989. Characterization of intrarenal arterial adrenergic receptors in renovascular hypertension. Hypertension 13:851-58
43. Birt PC, Zimmerman BG. 1995. Intrarenal arterial network renin content and inhibition by EMD 58265. Am J. Hypertension 8:433-36
44. Zimmerman BG, Birt PC. 1992. β-adrenoceptor-mediated angiotensin II release from rabbit intrarenal arterial network. Hypertension 20:436 (Abstr.)
45. Zimmerman BG, Birt PC. 1997. Angiotensin II release from rabbit intrarenal arteries: a critical assessment. Am. J. Hypertension. In press
46. Gomez RA, Lynch KR, Chevalier RL, Everett AD, Johns DW, et al. 1988. Renin and angiotensinogen gene expression and intrarenal renin distribution during ACE inhibition. Am. J. Physiol. 254:F900-6
47. Gomez RA, Lynch KR, Sturgill BX, Elwood JP, Chevalier RL, et al. 1989. Distribution of renin mRNA and its protein in the developing kidney. Am. J. Physiol. 257:F850-58
48. Tufro-McReddie A, Arrizurieta EE, Brocca S, Gomez RA. 1992. Dietary protein modulates intrarenal distribution of renin and its mRNA during development. Am. J. Physiol. 263:F427-35
49. Taugner C, Poulsen K, Hackenthal E, Taugner R. 1979. Immunocytochemical localization of renin in mouse kidney. Histochemistiy 62:19-27
50. Menard J, N'Goc PW, Bariety J, Guyenne PT, Corvol P. 1979. Direct radioimmunoassay and immunocytochemical localization of renin in human kidneys. Clin. Sci. 57:105S-8S
51. Lindop GBM. 1987. Morphological aspects of renin synthesis, processing, storage and secretion. Kidney Int. 31(Suppl. 20):S18-24
52. Danser AH, Koning MMG, Admiraal PJJ, Sassen LMA, Derkx FHM, et al. 1992. Production of angiotensins I and II at tissue sites in intact pigs. Am. J. Physiol. 263:H429-37
53. Danser AH, Koning MMG, Admiraal PJJ, Derkx FHM, Verdouw PD, Schalekamp MADH. 1992. Metabolism of angiotensin I by different tissues in the intact animal. Am. J. Physiol. 263:H418-28
54. 125I] labelled angiotensin I in isolated perfused porcine coronary and carotid arteries. Cardiovasc. Res. 29:789-95
55. Nussberger J, Brunner DB, Waeber B, Brunner HR. 1988. In vitro renin inhibition to prevent generation of angiotensins during determination of angiotensin I and II. Life Sci. 42:1683-88
56. Kohara K, Tabuchi Y, Senanayake P, Brosnihan KB, Ferrario CM. 1991. Reassessment of plasma angiotensins measurement: Effects of protease inhibitors and sample handling procedures. Peptides 12:1135-41
57. Campbell DJ, Duncan A-M, Kladis A, Harrap SB. 1995. Angiotensin peptides in spontaneously hypertensive and normotensive Donryu rats. Hypertension 25:928-34
58. Schwieler JH, Nussberger J, Kahan T, Hjemdahl P. 1994. Angiotensin II overflow from canine skeletal muscle in vivo: importance of plasma angiotensin I. Am. J. Physiol. 266:R1664-69
59. Caputo L, Tedgui A, Levy BI. 1995. Control of carotid vasomotor tone by local renin-angiotensin system in normotensive and spontaneously hypertensive rats. Role of endothelium and flow. Circ. Res. 77:303-9
60. Vicaut E, Hou X. 1993. Arteriolar constriction and local renin-angiotensin system in rat microcirculation. Hypertension 21:491-97
61. Campbell-Boswell M, Robertson AL. 1981. Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro. Exp. Mol. Path 35:265-76
62. Geisterfer AAT, Peach MJ, Owens GK. 1988. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ. Res. 62:749-56
63. Berk BC, Vekshtein V, Gordon HM, TsudaT. 1989. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 13:305-14
64. Duff JL, Berk BC. 1995. Angiotensin II-mediated signal transduction events in vascular smooth muscle cells: kinases and phosphatases. Blood Pressure 4(Suppl. 2):55-60
65. 2+ mobilization and protein kinase C activation. J. Biol. Chem. 264:526-30
66. Baker KM, Singer HA, Aceto JF. 1989. Angiotensin II receptor-mediated stimulation of cytosolic-free calcium and inositol phosphates in chick myocytes. J. Pharmacol. Exp. Ther. 251:578-85
67. Sadoshima J, Izumo S. 1993. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts: critical role of the AT1 receptor subtype. Circ. Res. 73:424-38
68. Sadoshima J, Xu Y, Slayter HS, Izumo S. 1993. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75:977-84
69. Yamazaki T, Komuro I, Kudoh S, Zou Y, Shiojima I, et al. 1995. Angiotensin II partly mediates mechanical stress-induced cardiac hypertrophy. Circ. Res. 77:258-67
70. Kojima M, Shiojima I, Yamazaki T, Komuro I, Zou Y, et al. 1994. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro. Circulation 89:2204-11
71. Kolpakov V, Sadoshima J, Izumo S, Kulik TJ. 1996. Angiotensin II mediates the stretch-induced increase in protein synthesis in rabbit aorta in vitro. FASEB J. 10:A18 (Abstr.)
72. Holycross BJ, Peach MJ, Owens GK. 1993. Angiotensin II stimulates increased protein synthesis, not increased DNA synthesis, in intact rat aortic segments, in vitro. J. Vasc. Res. 30:80-86
73. Swartz SL, Williams GH, Hollenberg NK, Moore TJ, Dluhy RG. 1979. Converting enzyme inhibition in essential hypertension: The hypotensive response does not reflect only reduced angiotensin II formation. Hypertension 1:106-11
74. Nussberger J, Brunner DB, Waeber B, Brunner HR. 1985. True versus immunoreactive angotensin II in human plasma. Hypertension 7(Suppl. I):Il-7
75. Nussberger J, Brunner DB, Waeber B, Brunner HR. 1986. Specific measurement of angiotensin metabolites and in vitro generated angiotensin II in plasma. Hypertension 8:476-82
76. Juillerat L, Nussberger J, Menard J, Mooser V, Christen Y, et al. 1990. Determinants of angiotensin II generated angiotensin II in plasma. Hypertension 16:564-72
77. Mento PF, Wilkes BM. 1987. Plasma angiotensins and blood pressure during converting enzyme inhibition. Hypertension 9(Suppl. III):III42-48
78. Merton JJ, Tree M, Casals-Stenzel J. 1980. The effect of captopril on blood pressure and angiotensins I, II and III in sodium-depleted dogs: problems associated with measurement of angiotensin II after inhibition of converting enzyme. Clin. Sci. 58:445-50
79. Schalekamp MADH, Derkx FHM, Van den Meiracker AH. 1992. Renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: relationships between blood pressure responses and effects on the renin-angiotensin system. J. Hypertension 10(Suppl. 7):S157-64
80. Li T, Zimmerman BG. 1992. Relation between inhibition of renal angiotensin II production and hemodynamic effect of captopril in anesthetized rabbit. J. Hypertension 10:795-802
81. Hollenberg NK, Fisher NDL. 1995. Renal circulation and blockade of the renin-angiotensin system. Is angiotensin-converting enzyme inhibition the last word? Hypertension 26:602-9
82. El Amrani A-I K, Menard J, Gonzales MF, Michel J-B. 1993. Effects of blocking the angiotensin II receptor, converting enzyme, and renin activity on the renal hemodynamics of normotensive guinea pigs. J. Cardiovasc. Pharmacol. 22:231-39
83. Campbell DJ, Lawrence AC, Towne A, Kladis A, Valentijn AJ. 1991. Differential regulation of angiotensin peptide levels in plasma and kidney of the rat. Hypertension 18:763-73
84. Mooser V, Nussberger J, Juillerat L, Burnier M, Waeber B, Bidiville J, et al. 1990. Reactive hyperreninemia is a major determinant of plasma angiotensin II during ACE inhibition. J. Cardiovasc. Pharmacol. 15:276-82
85. Mizuno K, Nakamaru M, Higashimori K, Inagami T. 1988. Local generation and release of angiotensin II in peripheral vascular tissue. Hypertension 11:223-29
86. Allan DR, McKnight JA, Kifor I, Coletti CM, Hollenberg NK. 1994. Converting enzyme inhibition and renal tissue angiotensin II in the rat. Hypertension 24:516-22
87. Chen K, Zimmerman BG. 1994. Comparison of renal hemodynamic effect of ramiprilat to captopril; possible role of kinins. J. Pharmacol. Exp. Ther. 270:491-97
88. Zhang X, Dunham EW, Zimmerman BG. 1995. Threshold sodium excretory and renal blood flow effects of angiotensin converting enzyme inhibition. J. Hypertension 13:1413-19